Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations
Francesca M Elli, Luisa de Sanctis, Valentina Bollati, et al.
European Journal of Endocrinology
|
August 13, 2009
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients
E Peverelli, F Ermetici, M Filopanti, et al.
Molecular and Cellular Endocrinology
|
November 28, 2020
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
E Giardino, R Catalano, F Mangili, et al.
European Journal of Endocrinology
|
December 3, 2020
Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients
Arrate Pereda, Francesca M Elli, Suzanne Thiele, et al.
Cancer Letters
|
October 19, 2020
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
R Catalano, E Giardino, D Treppiedi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 20, 2012
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs
Erika Peverelli, Giovanna Mantovani, Eleonora Vitali, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 12, 2010
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients
Giovanna Mantovani, Luisa de Sanctis, Anna Maria Barbieri, et al.
Histopathology
|
February 28, 2017
Fibrocartilaginous mesenchymoma of bone: a single-institution experience with molecular investigations and a review of the literature
Marco Gambarotti, Alberto Righi, Daniel Vanel, et al.
British Journal of Haematology
|
July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Elena Crisà, Daniela Cilloni, Elena M Elli, et al.
European Journal of Human Genetics : EJHG
|
July 10, 2014
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
Intza Garin, Giovanna Mantovani, Urko Aguirre, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Endocrinology and Metabolism
|
January 16, 2014
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations
Francesca M Elli, Luisa de Sanctis, Valentina Bollati, et al.
European Journal of Endocrinology
|
August 13, 2009
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients
E Peverelli, F Ermetici, M Filopanti, et al.
Molecular and Cellular Endocrinology
|
November 28, 2020
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
E Giardino, R Catalano, F Mangili, et al.
European Journal of Endocrinology
|
December 3, 2020
Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients
Arrate Pereda, Francesca M Elli, Suzanne Thiele, et al.
Cancer Letters
|
October 19, 2020
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
R Catalano, E Giardino, D Treppiedi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 20, 2012
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs
Erika Peverelli, Giovanna Mantovani, Eleonora Vitali, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 12, 2010
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients
Giovanna Mantovani, Luisa de Sanctis, Anna Maria Barbieri, et al.
Histopathology
|
February 28, 2017
Fibrocartilaginous mesenchymoma of bone: a single-institution experience with molecular investigations and a review of the literature
Marco Gambarotti, Alberto Righi, Daniel Vanel, et al.
British Journal of Haematology
|
July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Elena Crisà, Daniela Cilloni, Elena M Elli, et al.
European Journal of Human Genetics : EJHG
|
July 10, 2014
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
Intza Garin, Giovanna Mantovani, Urko Aguirre, et al.
Page
of 13